Rapid Diagnostic Tests and Their Effect on Antimicrobial Stewardship
T2 Biosystems Readies Biothreat Panel for FDA Submission While Keeping Eye on Sepsis Market
Increasing HAIs due to COVID-19 Stress the Need for a New Approach to Sepsis Diagnostics
HHS, Cohen Foundation Award $1M to Lyme Disease Dx Research Projects
T2 Biosystems awarded 100K for Lyme panel from HHS, Steven & Alexandra Cohen Foundation
Real-World Reports About Rapid Diagnostic Testing
T2 Biosystems inks distribution agreement in Baltic region
FDA grants breakthrough device designation for T2 Biosystems’ T2Lyme Panel
